Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03393364 · ClinicalTrials.gov registry record · Early Phase 1
Pain Management in Outpatient Urologic Procedures
A Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 150
- Enrollment target
NCT03393364: Completed Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
NCT03393364 is a Early Phase 1 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 150 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (183% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03393364, a Early Phase 1 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 150 participants
- Enrollment target
Study Summary
Goal of this study is to evaluate how pain is controlled after outpatient urologic surgeries. Patients will receive either opioid pain medication or non-opioid medication for pain control. A survey will be conducted at the post-operative appointment to evaluate for pain control.
Primary Outcome
Survey evaluating how well pain was controlled
Interventions
- DRUG Ketorolac
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2020-06-01 |
| Phase | Early Phase 1 |
What the finished NCT03393364 record still lists
NCT03393364 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (183% higher).
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT03393364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03393364 about?
NCT03393364 is a clinical study titled "Pain Management in Outpatient Urologic Procedures". Goal of this study is to evaluate how pain is controlled after outpatient urologic surgeries. Patients will receive either opioid pain medication or non-opioid medication for pain control. A survey will be conducted at the post-operative appointment to evaluate for pain control.
What is the current status of trial NCT03393364?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 150 participants. The study started on 2018-04-01. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03393364?
The interventions under investigation include: Ketorolac (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT03393364?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03393364's enrollment target sits among peer trials
150 100th of 2000 higher than 1,895 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI